Global law firm Norton Rose Fulbright has advised the ACG consortium comprising BP, Chevron, INPEX, Statoil, ExxonMobil, TP, ITOCHU and ONGC Videsh on the agreement with the Azerbaijan Government and the State Oil Company of the Republic of Azerbaijan (SOCAR).
September 15, 2017
Global law firm Norton Rose Fulbright was named M&A team of the year at the 2017 Legal Week Africa Awards.
American International Group, Inc. (NYSE: AIG), advised by global law firm Norton Rose Fulbright, has placed the first Shariah-compliant insurance policy in the Middle East and North Africa region (MENA) for merger and acquisitions activity.
September 13, 2017
Global law firm Norton Rose Fulbright today announced that experienced energy and resources lawyer Shamim Razavi will join as a corporate and M&A partner in the Sydney office.
September 11, 2017
Global law firm Norton Rose Fulbright has advised S-OIL Corp, one of South Korea’s largest refiners, on a 15-year, long-term liquefied natural gas (LNG) supply contract with Petronas LNG Ltd., a subsidiary of Malaysian state-owned enterprise Petroliam Nasional (PETRONAS).
September 08, 2017
Global law firm Norton Rose Fulbright and Levy, Stopol & Camelo, LLP have advised VOXX International on the sale of Hirschmann Car Communication to Swiss-headquartered TE Connectivity.
September 07, 2017
August 31, 2017
Global law firm Norton Rose Fulbright today announced further appointments in Australia for its national corporate team, welcoming another new partner and a special counsel with deep industry and cross-border experience.
August 25, 2017
Global law firm Norton Rose Fulbright has advised on certain international aspects of the TZS 476 billion (approximately US$215 million) initial public offering of Vodacom Tanzania Public Limited Company, a leading telecommunications provider in Tanzania.
August 22, 2017
Global law firm Norton Rose Fulbright has acted as the Australian legal advisers to the Walter and Eliza Hall Institute of Medical Research on the partial monetisation of a royalty due for sales of venetoclax, a new anti-cancer drug.
August 21, 2017
Try searching our global site instead